{"transactions":[{"id":851629,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Option to Purchase Common Stock","published_at":"2026-03-10T23:18:55.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":1546,"price":33.51,"value":51806.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was November 1, 2023."}],"balance_after":67678,"derivative":{"exercise_price":33.51,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":1546},"source":{"system":"sec-edgar","filing":"0001159036-26-000033","document":"wk-form4_1773184732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000033/wk-form4_1773184732.xml","form_type":"4"}},{"id":851628,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Option to Purchase Common Stock","published_at":"2026-03-10T23:18:55.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":33.51,"value":670200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was November 1, 2023."}],"balance_after":69224,"derivative":{"exercise_price":33.51,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001159036-26-000033","document":"wk-form4_1773184732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000033/wk-form4_1773184732.xml","form_type":"4"}},{"id":851627,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:18:55.000Z","date":"2026-03-10","kind":"sale","planned":false,"acquired":false,"shares":8857,"price":67.64,"value":599087.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $67.520 to $67.785. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":7055,"source":{"system":"sec-edgar","filing":"0001159036-26-000033","document":"wk-form4_1773184732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000033/wk-form4_1773184732.xml","form_type":"4"}},{"id":851626,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:18:55.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":1546,"price":33.51,"value":51806.46,"ownership":{"direct":true},"balance_after":15912,"source":{"system":"sec-edgar","filing":"0001159036-26-000033","document":"wk-form4_1773184732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000033/wk-form4_1773184732.xml","form_type":"4"}},{"id":851625,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:18:55.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":2100,"price":68.252,"value":143329.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $68.210 to $68.320. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":14366,"source":{"system":"sec-edgar","filing":"0001159036-26-000033","document":"wk-form4_1773184732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000033/wk-form4_1773184732.xml","form_type":"4"}},{"id":851624,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:18:55.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":17900,"price":67.751,"value":1212742.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $67.210 to $68.195. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":16466,"source":{"system":"sec-edgar","filing":"0001159036-26-000033","document":"wk-form4_1773184732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000033/wk-form4_1773184732.xml","form_type":"4"}},{"id":851623,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T23:18:55.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":33.51,"value":670200.0,"ownership":{"direct":true},"balance_after":34366,"source":{"system":"sec-edgar","filing":"0001159036-26-000033","document":"wk-form4_1773184732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000033/wk-form4_1773184732.xml","form_type":"4"}},{"id":885570,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-02-24T23:19:02.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":2666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":7998,"derivative":{"exercise_price":0,"exercise_date":"2026-02-20","underlying":"Common Stock","underlying_shares":2666},"source":{"system":"sec-edgar","filing":"0001159036-26-000031","document":"wk-form4_1771975140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000031/wk-form4_1771975140.xml","form_type":"4"}},{"id":885569,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-02-24T23:19:02.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1037,"price":70.98,"value":73606.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 1,037 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations."}],"balance_after":14366,"source":{"system":"sec-edgar","filing":"0001159036-26-000031","document":"wk-form4_1771975140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000031/wk-form4_1771975140.xml","form_type":"4"}},{"id":885568,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-02-24T23:19:02.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":2666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15403,"source":{"system":"sec-edgar","filing":"0001159036-26-000031","document":"wk-form4_1771975140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000031/wk-form4_1771975140.xml","form_type":"4"}},{"id":910296,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Performance Stock Units","published_at":"2026-02-12T02:21:33.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":14751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units (\"PSUs\") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units (\"PSUs\") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date."}],"balance_after":14751,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":14751},"source":{"system":"sec-edgar","filing":"0001159036-26-000017","document":"wk-form4_1770862890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000017/wk-form4_1770862890.xml","form_type":"4"}},{"id":910295,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Performance Stock Units","published_at":"2026-02-12T02:21:33.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":2403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units (\"PSUs\") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units (\"PSUs\") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date."}],"balance_after":13886,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2403},"source":{"system":"sec-edgar","filing":"0001159036-26-000017","document":"wk-form4_1770862890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000017/wk-form4_1770862890.xml","form_type":"4"}},{"id":910294,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-02-12T02:21:33.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":13047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."}],"balance_after":13047,"derivative":{"exercise_price":0,"exercise_date":"2027-02-09","underlying":"Common Stock","underlying_shares":13047},"source":{"system":"sec-edgar","filing":"0001159036-26-000017","document":"wk-form4_1770862890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000017/wk-form4_1770862890.xml","form_type":"4"}},{"id":910293,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Option to Purchase Common Stock","published_at":"2026-02-12T02:21:33.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":14047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and then 1/48th monthly thereafter."}],"balance_after":14047,"derivative":{"exercise_price":80.48,"exercise_date":"2027-02-09","expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":14047},"source":{"system":"sec-edgar","filing":"0001159036-26-000017","document":"wk-form4_1770862890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000017/wk-form4_1770862890.xml","form_type":"4"}},{"id":962303,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-12-19T22:39:43.000Z","date":"2025-11-01","kind":"exercise","planned":false,"acquired":false,"shares":9326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":18651,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9326},"source":{"system":"sec-edgar","filing":"0001159036-25-000075","document":"wk-form4_1766183980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000075/wk-form4_1766183980.xml","form_type":"4"}},{"id":962302,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-12-19T22:39:43.000Z","date":"2025-11-01","kind":"sale","planned":false,"acquired":false,"shares":4263,"price":65.19,"value":277904.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 4,263 shares represents the shares that were withheld and sold by the issuer as payment for tax withholding obligations."}],"balance_after":12737,"source":{"system":"sec-edgar","filing":"0001159036-25-000075","document":"wk-form4_1766183980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000075/wk-form4_1766183980.xml","form_type":"4"}},{"id":962301,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-12-19T22:39:43.000Z","date":"2025-11-01","kind":"exercise","planned":false,"acquired":true,"shares":9326,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17000,"source":{"system":"sec-edgar","filing":"0001159036-25-000075","document":"wk-form4_1766183980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000115903625000075/wk-form4_1766183980.xml","form_type":"4"}},{"id":1023561,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-10-06T21:18:03.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":3625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."}],"balance_after":3625,"derivative":{"exercise_price":0,"exercise_date":"2026-10-03","underlying":"Common Stock","underlying_shares":3625},"source":{"system":"sec-edgar","filing":"0002090209-25-000005","document":"form4-10062025_091000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000209020925000005/form4-10062025_091000.xml","form_type":"4"}},{"id":1023560,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":61808,"kind":"person","name":"Caudill Cortney","position":1,"cik":"0002090209","reported_name":"Caudill Cortney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF OPERATING OFFICER"}}],"security":"Option to Purchase Common Stock","published_at":"2025-10-06T21:18:03.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":9031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and then 1/48th monthly thereafter."}],"balance_after":9031,"derivative":{"exercise_price":68.98,"exercise_date":"2026-10-03","expiration_date":"2035-10-03","underlying":"Common Stock","underlying_shares":9031},"source":{"system":"sec-edgar","filing":"0002090209-25-000005","document":"form4-10062025_091000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000209020925000005/form4-10062025_091000.xml","form_type":"4"}}]}